Vascular endothelial cell growth factor (VEGF) serum concentrations change according to the phase of the menstrual cycle [4]

European Journal of Cancer

Volumn 34, Issue 8, 1998, Pages 1298-1299

  Benoy, I ^a   Vermeulen, P ^a   Wuyts, H ^a   Dirix, L ^a  

^a Oncology Centre of Antwerp   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ADULT; CLINICAL ARTICLE; FEMALE; HUMAN; LETTER; MENSTRUAL CYCLE; MENSTRUATION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

BIOLOGICAL MARKERS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MENSTRUAL CYCLE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032127844     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00066-5     Document Type: Letter

References (4)

1. 1. Findlay JK. Angiogenesis in reproductive tissues. J Endocr 1986, 111, 357-366.
2. 2. Dirix LY, Vermeulen PB, Hubens G, et al. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol 1996, 7, 843-848.
3. 3. Dirix LY, Vermeulen PB, Pawinski A, et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 1997, 76, 238-243.
4. 4. Bogden AE, Moreau J-P, Eden PA. Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 1997, 75, 1021-1027.